GENEVA, July 18 -- BELENOS BIOSCIENCES, INC. filed a patent application (US2026/010415) for “COMPOSITIONS AND METHODS OF USE OF ANTIBODIES TARGETING TSLP AND IL-13”. With publication no. WO/2026/151750, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 39/35
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....